Design Therapeutics Inc DSGN Q1 2026 Earnings Narrower Loss Surpasses Expectations Amid Quiet Quarter GLDD Q4 2025 Earnings Strong EPS Beat Driven by Operational Efficiency PRLD Q1 2026 Earnings NarrowerthanExpected Loss Amid Continued Pipeline Execution FTAIM Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds PARR Q1 2026 Earnings Earnings Miss Weighs on Results but Stock Edges Higher